Sartorius AG
OTC: SARTF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Michael Grosse
- Employees
- 13,985
- Headquarters
- Goettingen, Germany
- IPO year
- 2010
- Market cap
- $13.3B
- Website
- https://www.sartorius.com
Loading SARTF…
Loading profile data…Frequently asked questions about SARTF
What does Sartorius AG (SARTF) do?
Sartorius AG engages in the provision of solutions for biopharmaceutical research. It operates through following divisions: Bioprocess Solutions (BPS), and Lab Products and Service (LPS). The Bioprocess Solutions division focuses on single-use solutions, helps customers manufacture biotech medications and vaccines safely and efficiently. The Lab...
Where does SARTF trade?
Sartorius AG (SARTF) trades on the Other OTC.
What sector is SARTF in?
Sartorius AG (SARTF) operates in the Healthcare sector, specifically in the Medical - Specialties industry.
Who is the CEO of Sartorius AG?
Michael Grosse is the chief executive officer of Sartorius AG (SARTF).
Where is Sartorius AG headquartered?
Sartorius AG is headquartered in Germany.
Does SARTF pay a dividend?
Yes — Sartorius AG (SARTF) paid a trailing twelve-month dividend of USD 0.84 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did SARTF go public?
Sartorius AG (SARTF) completed its initial public offering in 2010.